Work

Comparative Study between Once Daily LABA-LAMA (Indacaterolglycopyrronium) vs. Twice Daily LABA-LAMA (Formoterolglycopyrronium) in Stable COPD Patients Group B

Year: 2025

Type: article

Study design: Clinical Trial

Source: Current Respiratory Medicine Reviews

DOI: 10.2174/011573398x352805250415083204

Authors: Neelam Verma, Avinash Kumar

Institutions: Fortis Healthcare, Fortis Flt. Lt. Rajan Dhall Hospital

Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409694590

FWCI:

Cites: 15

Cited by:

Related to: 10